Zurcher Kantonalbank (Zurich Cantonalbank) Travere Therapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 19,969 shares of TVTX stock, worth $366,830. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,969

Previous 19,969 -0.0%

Holding current value

$366,830

Previous $279,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$7.89 - $15.21 $27,283 - $52,596	3,458 Added 20.94%	19,969 $279,000
Q3 2023 Oct 25, 2023	BUY	$7.64 - $17.25 $30,613 - $69,120	4,007 Added 32.05%	16,511 $147,000
Q2 2023 Aug 07, 2023	BUY	$15.3 - $22.61 $2,952 - $4,363	193 Added 1.57%	12,504 $192,000
Q1 2023 May 08, 2023	BUY	$17.82 - $22.89 $51,303 - $65,900	2,879 Added 30.52%	12,311 $276,000
Q4 2022 Feb 01, 2023	BUY	$18.47 - $26.14 $35,610 - $50,397	1,928 Added 25.69%	9,432 $198,000
Q2 2022 Aug 09, 2022	SELL	$20.94 - $30.01 $45,418 - $65,091	-2,169 Reduced 22.42%	7,504 $182,000
Q1 2022 Apr 21, 2022	SELL	$23.61 - $30.6 $23,916 - $30,997	-1,013 Reduced 9.48%	9,673 $249,000
Q4 2021 Feb 01, 2022	BUY	$24.34 - $31.17 $73,166 - $93,697	3,006 Added 39.14%	10,686 $332,000
Q3 2021 Nov 15, 2021	BUY	$12.98 - $25.03 $51 - $100	4 Added 0.05%	7,680 $186,000
Q2 2021 Jul 30, 2021	BUY	$14.11 - $26.4 $1,255 - $2,349	89 Added 1.17%	7,676 $112,000
Q1 2021 May 03, 2021	SELL	$23.37 - $31.77 $3,435 - $4,670	-147 Reduced 1.9%	7,587 $189,000
Q4 2020 Jan 28, 2021	BUY	$19.17 - $27.87 $148,260 - $215,546	7,734 New	7,734 $211,000

Others Institutions Holding TVTX

# of Institutions

193

Shares Held

83.6M

Call Options Held

776K

Put Options Held

900K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.18B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Travere Therapeutics, Inc. Transaction History